SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kabra Drugs - Quaterly Results

14 Feb 2024 Evaluate
The revenue for the December 2023 quarter is pegged at Rs. 0.00 millions against Rs. 0.00 millions recorded during the year-ago period.The Net Loss for the quarter ended December 2023 is Rs. -1.09 millions as compared to Net Loss of Rs. -0.60 millions of corresponding quarter ended December 2022 Operating profit Margin for the quarter ended December 2023 further decreased to -1.09% as compared to -0.60% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.06 0.00 0.00 0.00 0.00
PBIDT -1.09 -0.60 81.67 -3.65 -1.96 86.22 -3.39 -1.75 93.71
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -1.09 -0.60 81.67 -3.65 -1.96 86.22 -3.39 -1.75 93.71
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 0.00
PBT -1.09 -0.60 81.67 -3.65 -1.96 86.22 -3.39 -1.85 83.24
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -1.09 -0.60 81.67 -3.65 -1.96 86.22 -3.39 -1.85 83.24
Equity 43.89 43.89 0.00 43.89 43.89 0.00 43.89 43.89 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 -5650.00 0.00 0.00

Kabra Drugs Share Price

28.29 -0.25 (-0.88%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×